Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Topical tacrolimus is effective and safe for treating alopecia areata.

The structured oral exam format is effective and well-received for teaching internal medicine.

Estrogens and progesterone are key in regulating melasma pigmentation.

Low-dose oral minoxidil is safe for treating children's hair disorders.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

RHUPUS should be considered in children with deforming arthritis.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

Nails can reveal important health information about skin and body conditions.

Patients with chronic renal failure on hemodialysis often have skin problems like dry skin, itching, and nail changes.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

A child with low platelets and anemia was later found to have lupus.

A man with painful ear plaques was diagnosed with discoid lupus and treated with medications and lifestyle changes.

Prolactin may be important for skin growth and immune function.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.